
AZTA · NASDAQ
Azenta, Inc.
$39.08 +0.66 (+1.81%)
Company overview
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments that help customers manage samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NASDAQ
- Market cap
- $1.7B
- Employees
- 3,000
- Headquarters
- Burlington, MA
- Website
- azenta.com
- CEO
- John Marotta
- Listed
- February 2, 1995
- P/E
- -9.89
- Dividend yield
- 0.37%
Company financials
- Revenue
- $597M
- Gross profit
- $266M
- Operating income
- -$15.6M
- EBITDA
- $49.2M
- Net income
- -$178M
- EPS
- -$3.95
- Total assets
- $1.9B
- Total debt
- $55.7M
- Gross margin
- 44.55%
- Net margin
- -29.86%
- Earnings yield
- -10.11%
Showing FY 2025